evertex fabrinology limited (TPE:1470)

TPE:1470 Revenue

evertex fabrinology limited had revenue of 180.32M TWD in the quarter ending June 30, 2026, a decrease of -9.24%. This brings the company's revenue in the last twelve months to 762.71M, down -7.41% year-over-year. In the year 2025, evertex fabrinology limited had annual revenue of 803.71M with 1.99% growth.

• Revenue (ttm): 762.71M
• Revenue Growth: -7.41%
• P/S Ratio: 2.70
• Revenue / Employee: 2.73M
• Employees: 279
• Market Cap: 2.06B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	803.71M	15.67M	1.99%
Dec 31, 2024	788.04M	132.82M	20.27%
Dec 31, 2023	655.22M	-189.93M	-22.47%
Dec 31, 2022	845.15M	-49.64M	-5.55%
Dec 31, 2021	894.79M	264.03M	41.86%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error